Home > Insider Trading > Filing (0001127602-23-014082)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
816956	Conmed Corp	CNMD	Electromedical & Electrotherapeutic Apparatus (3845)	160977505

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1635424	M Terence Berge	C/O Conmed Corporation 11311 Concept Boulevard Largo FL 33773	Vp-Corporate Controller	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-04-28	2,800	$41.93	3,804	No	4	M	Direct
Common Stock	Acquisiton	2023-04-28	5,400	$59.96	9,204	No	4	M	Direct
Common Stock	Acquisiton	2023-04-28	5,400	$78.76	14,604	No	4	M	Direct
Common Stock	Acquisiton	2023-04-28	5,100	$97.69	19,704	No	4	M	Direct
Common Stock	Disposition	2023-04-28	2,800	$127.44	16,904	No	4	S	Direct
Common Stock	Disposition	2023-04-28	5,400	$126.78	11,504	No	4	S	Direct
Common Stock	Disposition	2023-04-28	5,400	$126.42	6,104	No	4	S	Direct
Common Stock	Disposition	2023-04-28	5,100	$126.65	1,004	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Options To Purchase Common Stock	Disposition	2023-04-28	2,800	$0.00	2,800	$41.93
Common Stock	Options To Purchase Common Stock	Disposition	2023-04-28	5,400	$0.00	5,400	$59.96
Common Stock	Options To Purchase Common Stock	Disposition	2023-04-28	5,400	$0.00	5,400	$78.76
Common Stock	Options To Purchase Common Stock	Disposition	2023-04-28	5,100	$0.00	5,100	$97.69

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2031-03-01	No	4	M	Direct
0	2028-03-01	No	4	M	Direct
2,700	2029-03-01	No	4	M	Direct
5,100	2030-03-02	No	4	M	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.25 to $127.80. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.60 to $127.23. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.54 to $126.99. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period